Long-Acting Injectable PrEP for HIV Prevention: Introducing Apretude (Cabotegravir) in Hong Kong | EU Health & Wellness

Long-Acting Injectable PrEP for HIV Prevention: Introducing Apretude (Cabotegravir) in Hong Kong

10018

Apretude is a revolutionary long-acting injectable PrEP designed to reduce the risk of HIV infection, offering an effective prevention option.

Long-Acting Injectable PrEP for HIV Prevention: Introducing Apretude (Cabotegravir) in Hong Kong

Apretude is a revolutionary long-acting injectable PrEP designed to reduce the risk of HIV infection, offering an effective prevention option.